Microbiome Test Interpretation Guide

Microbiome tests vary widely in what they measure and how reliable their outputs are. This guide outlines the main test types and a simple framework for deciding what to trust.

Common test types

16S rRNA sequencing

16S tests read short genetic markers to identify bacteria, usually to the genus level. They are relatively affordable and widely used, but they miss many microbes (including most viruses and fungi) and cannot reliably distinguish closely related species.

Shotgun metagenomics

Shotgun sequencing reads DNA across the whole sample. It can identify more species and genes than 16S, including some functional pathways. It is more expensive and still affected by sample handling, depth limits, and database quality.

Biomarker panels

Some tests report calculated scores, ratios, or proprietary indexes rather than raw species lists. These can be easy to read but often combine many assumptions. Always ask what data and evidence underpin a given score.

High vs. low reliability signals

Higher reliability

• Presence or absence of well-characterized species detected with appropriate methods
• Large, consistent shifts in diversity or dominant taxa across repeated samples
• Findings that match established reference ranges for the same assay and lab
• Results supported by replicated human studies, not single small cohorts

Lower reliability

• Single-timepoint results interpreted as long-term health status
• Species-level calls from 16S data where resolution is uncertain
• Proprietary “optimal range” flags without published validation
• Links between one microbe and a specific symptom, diet, or diagnosis
• Recommendations for supplements or strict diets based only on one test

A simple interpretation framework

What can often be acted on

• Follow-up with a qualified clinician when results are part of a broader clinical picture
• Tracking broad patterns over time with the same lab and method
• Using well-supported lifestyle changes (diet diversity, fiber, sleep) when appropriate—not because one microbe was “low”
• Treating extreme or inconsistent results as prompts for repeat testing, not diagnosis

What should stay uncertain

• Whether a detected microbe is causing symptoms or merely co-occurring
• Whether a value is “good” or “bad” for you personally
• Whether a specific probiotic or elimination diet will change outcomes
• Any single-result claim about disease risk or treatment response